Is Gen AI ready for life sciences? This month, Dom Tyer looks at the explosive growth of Gen AI, saying that it “has caused plenty of consternation as well as celebration, but there’s no turning back ...

FRONTERA GROUP is a cross-functional blend of behaviour and creative engagement experts. Our approach identifies the underlying drivers of decision making, to uncover how choices are made today and ...

A dynamic medical communications agency helping innovative life sciences companies to Be Heard, Be Understood & Be the Difference.

The announcement comes just a few months after WHO released its 2024 Bacterial Priority Pathogens List, which highlights the ...

Novo Nordisk has shared promising results from a late-stage study of semaglutide in patients with metabolic ...

The National Institute for Health and Care Excellence (NICE) has recommended Blueprint Medicines’ Ayvakyt (avapritinib) to ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the European Commission (EC) to treat eosinophilic ...

The companies will use Ascendis’ TransCon technology to develop therapies for metabolic and cardiovascular diseases ...

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and ...

EatMoreFruit, a UK top 10 independent healthcare communication agency, today announced the launch of its European Network to ...

AstraZeneca’s Fasenra (benralizumab) has been approved by the European Commission (EC) to treat eosinophilic granulomatosis with polyangiitis (EGPA), a rare immune-mediated inflammatory disease that ...

GCI Health has announced the appointment of Annalise Coady as president, UK market lead and EMEA head of growth. Coady brings over two decades of experience in building and scaling marketing ...